Selective serotonin reuptake inhibitors (SSRI) and serotonin-norepinephrine reuptake inhibitors (SNRI) are popular classes of antidepressants prescribed to a variety of patients suffering from emotional and cognitive disorders. Various studies have suggested that, while their benefits outweigh the risks for most patients, a point of concern remains when women who become pregnant – or are thinking of becoming pregnant – continue on the medication through the course of their pregnancy. Also, there is concern even when the drugs are taken only during a part of the pregnancy.
SSRI antidepressants have been known, in rare cases, to foster birth defects in babies. Both SSRIs and SNRIs increase levels of serotonin in the brain. But SNRI medications also affect the levels of norepinephrine in the patient’s brain. Various studies have also suggested SSRI antidepressants can trigger PPHN, or persistent pulmonary hypertension of the newborn, a rare condition involving the lungs. If you need more information please contact Roger Smith, a lawyer in our Mass Torts Section, at 800-898-2034 or by email at Roger.Smith@beasleyallen.com.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.